Puerto Ricans fear for their health as federal cuts loom

Fresno Bee - 2 weeks ago
Unable to walk, he lurches about...

Paramedic Hybrid Education Programs Brings Learning Opportunities to Everyone

JEMS.com - 4 weeks ago
It may bring in the use of a...

Facebook's new fundraiser tool makes it easier for nonprofits to raise money

Voice Chronicle - 2 weeks ago
In 2014, millions of people –...

Taking page from early AIDS activists, ALS patients push for access to ...

San Francisco Business Times (blog) - 4 months ago
Ultimately, they hope to convince...

Expanding Access To Experimental Drugs

Mondaq News Alerts (registration) - 6 months ago
Accordingly, more sophisticated...

ALS Drug Access Debated

The Scientist - 8 months ago
In addition to the Phase 2...

Unsere gemeinsame Herausforderung

derStandard.at - 2 weeks ago
Mehr als 90 Prozent der syrischen...

'Right To Try' bill: Brown rejects proposal to let terminal patients use ...

San Jose Mercury News - 2 months ago
Despite his landmark decision last...

The flimsy case for a miracle ALS drug collapses under expert scrutiny

FierceBiotech - 7 months ago
And the study was so tiny that...

Everything you need to know about YouTube Red

CNET - 1 month ago
... as YouTube Music Key, a...

News via Google. See more news matching 'als expanded access'


Expanded Access

Bringing Research and Patients Together

Our Expanded Access platform is meant to do two things:

  1. Empower patients with access to new treatments that are in clinical research.
  2. Empower further research with clinical data from those patients.

For someone with a quick-killer disease, participating in clinical research may be the only way to access a new medicine that might help him live longer.  He may be willing to accept some uncertainty, considering the alternative.  So for patients, there’s a lot of overlap between treatment exploration and research.

But what about patients who cannot get into clinical trials?  Can they still take part in research and explore investigational treatment?

Yes, they can, but only through what are called Expanded Access programs (EAPs).  These are meant to include a much broader group of patients than traditional clinical trials, sometimes exclusively those patients who don’t meet clinical trial enrollment criteria or who otherwise cannot get into trials.

ALS-ETF is bringing a new kind of Expanded Access to the ALS community, to make a groundbreaking impact in the treatment landscape for patients as well as the research that’s powered by patient data.

Learn more about Expanded Access programs here.

Learn more about our research goals here.